Recruiting PHASE4 HPV

New treatment option for HPV

Official title A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

ClinicalTrials.gov ID: NCT05495906

What this study is testing

What is Nonavalent HPV vaccine?

Nonavalent HPV vaccine is an investigational medicine, being studied as a potential treatment for hpv.

Also referred to as Gardasil9.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
There are very little data on human papillomavirus (HPV) vaccination among the 18 million women living with HIV (WLWH) globally, who constitute a population most vulnerable to HPV and the resultant cervical cancer. Particularly, there are no data to date on reduced-dose schedules of nonavalent HPV (9vHPV) vaccination in WLWH and there are very little data on the 9vHPV vaccine in this population overall.
  • Phase 4: studies an already-approved treatment
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Living with HIV
  • Has a uterine cervix

You likely can't join if

  • Unable to give fully informed consent
  • Pregnant or unwilling to avoid pregnancy during vaccination
  • Allergy to the vaccine or its components
  • Prior receipt of any HPV vaccine

The study team makes the final eligibility decision.

Where it's taking place

  • Surrey, British Columbia, Canada
  • Vancouver, British Columbia, Canada
  • Winnipeg, Manitoba, Canada
  • Hamilton, Ontario, Canada
  • Toronto, Ontario, Canada
  • Montreal, Quebec, Canada
  • Québec, Quebec, Canada
  • Regina, Saskatchewan, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Surrey, British Columbia, Canada; Vancouver, British Columbia, Canada; Winnipeg, Manitoba, Canada; Hamilton, Ontario, Canada; Toronto, Ontario, Canada; Montreal, Quebec, Canada and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.